Invion Limited

ASX (AUD): Invion Limited (IVX)

Last Price

0.08

Today's Change

-0.003 (3.61%)

Day's Change

0.08 - 0.08

Trading Volume

1

Overview

Market Cap

6 Million

Shares Outstanding

77 Million

Avg Volume

93,337

Avg Price (50 Days)

0.10

Avg Price (200 Days)

0.20

PE Ratio

-0.73

EPS

-0.11

Earnings Announcement

28-Feb-2025

Previous Close

0.08

Open

0.08

Day's Range

0.08 - 0.08

Year Range

0.079 - 0.5

Trading Volume

1

Price Change Highlight

1 Day Change

-3.61%

5 Day Change

-11.11%

1 Month Change

-20.00%

3 Month Change

-33.33%

6 Month Change

-61.90%

Ytd Change

-70.59%

1 Year Change

-60.00%

3 Year Change

-60.00%

5 Year Change

-60.00%

10 Year Change

-60.00%

Max Change

-60.00%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Drug Manufacturers—Specialty & Generic

Description:

Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company was incorporated in 2000 and is headquartered in Melbourne, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment